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Abstract 
Background: In Staphylococcus aureus aminoglycosides and methicillin resistance 
are closely associated. We aimed at detection of the prevalence of methicillin and 
aminoglycosides resistances in S. aureus isolated from surgical intensive care units 
(ICUs) in Kasr-Al-Aniy hospitals, the association of mecA gene and aminoglyco-
side modifying enzymes (AMEs) genes among these isolates and the accuracy of 
cefoxitin disc diffusion method in relation to PCR. 
Methods: A total of 150 clinical samples were collected. Cultivation and identifica-
tion of isolates were done by the standard microbiological techniques. All S. aureus 
isolates were tested for methicillin and aminoglycosides resistance by disc diffusion 
method and for presence of mecA gene and AMEs genes by multiplex-PCR. 
Results: A high rates of mecA gene (89.58%) and AME genes (60.42%) were 
found in 48 S. aureus isolates (32%). Co-existence of mecA gene with one or 
more of AME genes was detected in 60% of the isolates. The mecA gene was 
detected in 87% of cefoxitin resistant isolates and aac(6’)-Ie+aph(2’’) was the most 
predominant AME genes. 
Conclusion: This study shows wide spread of mecA gene in association with 
aminoglycoside modifying enzymes in the ICUs of Kasr-Al-Aniy hospitals in Cairo.
Keywords: S. aureus - mecA gene - aminoglycoside modifying enzymes genes 
-PCR
Introduction
Staphylococcus aureus (S. aureus) , in particular, methicillin-
resistant S. aureus (MRSA) has long been responsible for 
a great deal of human morbidity and mortality. MRSA are 
increasingly important causes of hospital and community 
acquired infections throughout the world, and most hos-
pital infections caused by S. aureus due to central venous 
catheter associated bacteraemia, lower respiratory tract in-
fection, skin and soft tissue infection as well as ventilator 
associated pneumonia (1, 2).
Multidrug resistance is becoming prevalent among Staphy-
lococcus aureus especially those isolated from intensive care 
units and from blood cultures worldwide (1). Inevitably this 
has left fewer effective antibiotics to treat these often life-
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threatening infections. As rapidly as new antibiotics are in-
troduced, staphylococci are developing efficient mechanisms 
to neutralize them (3). 
Because the aminoglycosides have a rapid and intense killing 
power, they have been commonly administered along with 
the glycopeptides in treatment of multidrug-resistant (MDR) 
S. aureus infections (4). Unlike most antibiotic inhibitors of 
protein synthesis in bacteria that lead to bacteriostasis, the 
aminoglycosides are potent bactericidal agents that inhibit 
bacterial protein synthesis by binding to the 30S ribosomal 
subunit and by disrupting the integrity of bacterial cell mem-
brane (5). 
Detection of mecA or the protein expressed by mecA, the 
PBP 2a or PBP 2’, are the most accurate methods for predic-
tion of resistance to oxacillin and can be used to confirm 
results for isolates of staphylococci from serious infections. 
Isolates of staphylococci that carry the mecA gene, or that 
produce PBP 2a should be reported as oxacillin resistant, and 
those isolates that do not carry mecA or do not produce 
PBP2a should be reported as oxacillin susceptible (6).
It is reported that S. aureus resistance to aminoglycosides is 
closely associated with methicillin resistance (7). The main 
mechanism of aminoglycoside resistance in staphylococci is 
drug inactivation by plasmid- or transposon-mediated cel-
lular aminoglycoside-modifying enzymes (AMEs) (8). These 
enzymes are of particular significance among staphylococci 
since they modify and thereby inactivate the aminoglycosides. 
The genes encoding such modifying enzymes include aac(6′)-
Ie+aph(2′′), aph(3′)-IIIa and ant(4′)-Ia (9). 
Susceptibility testing for individual aminoglycoside antibiot-
ics is usually performed in clinical microbiology laboratories 
by disc diffusion or measurement of the minimal inhibitory 
concentration (MIC) of the antibiotic (10). However, such re-
sistance does not discriminate between the types of enzymes, 
which might be present in a bacterial isolate (11). This limita-
tion has been addressed by the use of genotypic methods in-
cluding dot blot hybridization and polymerase chain reaction 
(PCR) for detecting the presence of genes encoding AMEs 
and specifying their types from Staphylococci (7).
The aim of this work was to investigate the prevalence of 
methicillin-resistant and aminoglycoside resistant Staphylo-
coccus aureus in surgical ICUs in Kasr-Al-Aniy hospitals and 
the association of mecA gene and AMEs genes among noso-
comial isolates of S. aureus, in addition, to test the accuracy 
of cefoxitin disc diffusion method in relation to PCR.
Materials and Methods
This study was conducted on 150 patients from the general 
surgery, orthopedic and neurosurgery intensive care units 
(I.C.Us) who were admitted to adult trauma and surgical pa-
tients in Kasr Al-Ainy hospitals, Cairo University. Ninety six 
males and 54 females with age between 24-59 years were 
included in the study. All laboratory tests were carried out 
in the department of Microbiology and Immunology, Faculty 
of Medicine, Cairo University during the period from March, 
2011 to September, 2012.
Sample collection
A total of 150 clinical samples of swabs, suction catheters and 
syringes were collected from 150 patients including 8 blood 
samples, 69 pus samples obtained from the floor and wall 
of abscesses after pus evacuation and surgical site infections 
from burn sites, 20 sputum samples, 32 endotracheal aspirate 
samples, one pleural aspirate sample and 20 catheter speci-
mens of urine . All specimens were labeled with the date, 
patient’s name and patient’s number, time of collection and 
specimen type, then transported immediately to the micro-
biology laboratory.
Cultivation of the specimens 
All specimens other than blood were cultured onto nutrient 
agar and blood agar plates (Oxoid Hampshire, England) and 
were incubated aerobically at 35°C 24 – 48 hours. Blood 
samples were inoculated into blood culture bottles (Oxoid , 
England) and mixed with the medium, then incubated aero-
bically at 35°C. Subcultures were done on blood agar plates 
every 2 days, and were incubated aerobically at 35°C 24 – 48 
hours to detect bacterial growth. The blood culture bottles 
were considered negative after 14 days if no growth on the 
subcultures was detected.
Identification of the isolates
Staphylococcus aureus isolates were identified by colony mor-
phology, Gram stained smear, catalase test and coagulase 
test (Plasma Coagulases EDTA Selectavial, MAST, USA). 
Detection of methicillin and aminoglycoside 
resistance among S. aureus isolates by disc 
diffusion method:
All S. aureus isolates were inoculated on Mueller-Hinton agar 
with 2% NaCl to test for oxacillin susceptibility, while Mueller-
Hinton agar was used for the other antibiotics. All inocu-
lated plates were incubated aerobically at 35°C for 24 hours. 
The following antibiotic discs were used: oxacillin (OX) 1µg, 
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cefoxitin (FOX) 30µg, gentamicin (CN) 10µg, amikacin (A) 
30µg, kanamycin (K) 30µg, netilmicin (NET) 30µg and to-
bramycin (T) 10µg. Inhibition zones of antibiotics were inter-
preted according to the CLSI guidelines (6). 
Genotypic detection of methicillin and 
aminoglycoside modifying enzyme resistance 
genes in S. aureus isolates using the multiplex-
PCR method
DNA Extraction from S. aureus isolates cultures was done 
using Biospin Bacteria Genomic DNA extraction kit (BioFlux 
corporation, Tokyo, Japan).
 
DNA amplification by Multiplex PCR was done using 
four sets of lyophilized primers specific for aac(6′)/aph(2′′), 
aph(3′)-IIIa, ant(4′)-Ia, and mecA gene that were designed 
from a site within the nucleotide sequence of the published 
region of each resistance gene (12) (table 1), Dream TaqTM 
Green PCR Master Mix (2X) 200 reactions of 50µl (Thermo-
Fermentas, California, USA) (ready-to use solution contain-
ing Dream TaqTM DNA polymerase, optimized Dream TaqT-
MGreen buffer, 4mµ MgCl2, density reagents, 2 dyes for 
monitoring electrophoresis process and 0.4 mµ from each 
of dATPs, dCTP, dGTP and dTTP) and Biometra T-Personal 
thermal cycler (48 wells, Ver 09/10, Germany).
Five µl of the extracted DNA was added to 25 µl of PCR 
master mix, 1 µ of each primer, 12 µl nuclease free water to 
reach a final volume of 50µl.
The amplification process was done as follows according 
to the manufacturer’s instructions and what was published 
before (12) as an initial denaturation cycle at 95 o C for 5 
minutes, 35 cycles consisted of denaturation at 95 o C for 
30 seconds, annealing at 48 o C for 30 seconds and primer 
extension at 72 o C for 30 seconds followed one cycle of final 
extension at 72 o C for 10 minutes.
At the end of amplification process, the maintenance tem-
perature was 4°C. 
Detection of the amplified products: The amplified DNA 
products sizes were detected using 2% agarose gel elec-
trophoresis, molecular size marker(100-1000 base pair) and 
were visualized by UV transilluminator (Biometra, TI ) 
Statistical Analysis
Data were statistically described in terms of frequencies 
(number of cases) and percentages. Comparison between 
the study groups was done using Chi square (c2) and McNe-
mar tests. Exact test was used instead when the expected 
frequency is less than 5. All statistical calculations were done 
using computer programs SPSS (Statistical Package for the 
Social Science; SPSS Inc., Chicago, IL, USA) version 15 for 
Microsoft Windows.
Results 
Bacterial growth with golden yellow pigment on nutrient agar, 
β-haemolysis on blood agar, Gram positive cocci in grape like 
clusters, positive catalase test and positive slide coagulase test 
was considered as S. aureus isolate. Nine bacterial isolates 
were Gram positive cocci in grape like clusters, catalase test 
positive, produced golden yellow pigment on nutrient agar 
and β-haemolysis on blood agar but they were coagulase 
negative by the slide coagulase test so they were examined 
with tube coagulase test and 6 isolates of them were posi-
tive and considered as S. aureus isolates. A total number of 
48/150 (32%) S. aureus isolates from clinical samples were 
isolated from general surgery, neurosurgery and orthopedic 
ICUs. The rest of the clinical samples revealed the presence 0f 
56 Gram negative bacilli (36 Enterobacteriaceae, 13 Pseudo-
monas and 7 Acinetobacter), 21 Coagulase negative staphy-
lococci, 5 Candida spp and 20 clinical samples were negative. 
The distribution of S. aureus isolates in specimens were the 
following: 19 (39.58%) from pus, abscess, surgical wound 
and burn site, 15 (31.25%) were from endotracheal aspirates, 
7 (14.58%) from blood, 3 (6.25%) from catheters of urine, 
3 (6.25) from sputum and one (2%) from pleural aspirate. 
The results of antibiotic susceptibility disc diffusion method 
indicated the following: 41/48 (85.42%) of S. aureus isolates 
were oxacillin resistant; 39 isolates of these oxacillin resistant 
strains (81.25%) were also cefoxitin resistant and 2 isolates 
of them (4.17%) were cefoxitin sensitive (out of a total 9 
cefoxitin sensitive isolates). None of these 2 oxacillin resis-
Table 1.  Specific primer sequences used in the detection of 
mecA and AME genes (12): 
Target 
genes Primer sequence 
Amplified 
product 
size
aac(6′)/
aph(2′′)
5′-GAAGTACGCAGAAGAGA-3′ 
5′-ACATGGCAAGCTCTAGGA-3′ 491 bp
aph(3′)-IIIa 5′-AAATACCGCTGCGTA-3′ 5′-CATACTCTTCCGAGCAA-3′ 242 bp
ant(4′)-Ia 5′-AATCGGTAGAAGCCCAA-3′ 5′-GCACCTGCCATTGCTA-3′ 135 bp
mecA 5′-CCTAGTAAAGCTCCGGAA-3′ 5′-CTAGTCCATTCGGTCCA-3′ bp
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tant / cefoxitin sensitive isolates were harbouring mecA gene. 
Out of the 48 S. aureus isolates (89.58%) were harboring 
mecA gene, 34 isolates of them were cefoxitin resistant (87% 
of all cefoxitin resistant S. aureus isolates) and 9 isolates of 
them were cefoxitin sensitive (100% of all cefoxitin sensi-
tive S. aureus isolates). There is no statistically significance 
(p value 0.256) between phenotypic cefoxitin resistance and 
genotypic results (Table 2). The results of antibiotic suscep-
tibility showed 29 isolates (60%) showed resistance to all 
aminoglycosides tested (Table 3). Also, 34 (87%) of MRSA 
isolates were resistant to gentamicin, 35 (90%) to Amikacin, 
38 (97%) to Kanamycin, 28 (72%) to Netilmicin and 34 (87%) 
to Tobramycin (Table 4).
 AME genes were detected in 29/48 (60.42%) of S. aureus 
isolates .The aac(6’)-Ie+aph(2’’) gene was present in 26/46 
(56.5%) aminoglycoside resistant S. aureus, and only one 
S. aureus isolate was susceptible to aminoglycoside, while 
aph(3’)-IIIa and ant(4’)-Ia were detected in 22/48 (48%) and 
1/46 (2%) of aminoglycoside resistant S. aureus, None of 
the AME genes were detected in 17 aminoglycoside resistant 
isolates (table 5). Of the 39 MRSA, 23 isolates (56%) were 
harbouring aac(6’)-Ie+aph(2’’) while aph(3’)-IIIa and ant(4’)-Ia 
were detected in 20 (51.28%) and 1 (2.56%) isolates, re-
spectively. In addition, aac(6’)-Ie+aph(2’’) was present in 4 / 
9 (44.44%) of MSSA isolates and aph(3’)-IIIa was present in 
2/9 MSSA (22.22%) isolates (Table 6).
 Out 48 S. aureus isolates, 14 isolates (29.16%) were har-
boring mecA gene alone without any AME genes, and only 
7 isolates (14.58%) were harboring mecA gene in combi-
nation with aac(6’)-Ie+aph(2’’) and 2 isolates (4.16%) were 
harboring mecA gene in combination with aph(3’)-IIIa. Also, 
20 isolates (41.66%) carried mecA gene in combination with 
aac(6’)-Ie+aph(2’’) and aph(3’)-IIIa There are statistical signifi-
cant correlations between mecA gene and aac(6’)-Ie+aph(2’’) 
(p value = 0. 007) and between mecA gene and aph(3’)-IIIa 
(p value = 0. 030). All the 20 isolates that harboring mecA 
gene in combination with aac(6’)-Ie+aph(2’’) and aph(3’)-
IIIa (100%) were resistant to gentamicin and kanamycin, 19 
isolates of them (95%) were resistant to amikacin and to-
bramycin and 16 (80%) isolates were resistant to netilmicin. 
There were 4 isolates without harboring mecA or any of the 
three aminoglycoside modifying enzymes genes and they 
showed resistance to all tested aminoglycosides. The aac(6’)-
Ie+aph(2’’) (27 isolates) were more frequently detected than 
aph(3’)-IIIa (22 isolates) and both genes were more often 
present together than single (Tables 7, 8 & 9).
Table 2.  Correlation between cefoxitin (FOX) resistance and 
the presence of mecA gene.
P value PCR results for mecA  No. of strains tested 
by disk diffusion 
with FOX
0.256
 No. of 
negative
No. of 
positive
 5  34 39 (resistant)
 0  9 9 (sensitive)
 5  43 Total = 48 Table 3.  The aminoglycoside resistance phenotype among 
all S. aureus isolates.
Phenotypic patterns
No. of S. 
aureus 
isolates
Frequency (%)
K 3 (6.5%)
K &A 2 (4%)
K, A &TOB 4 (8.7%)
K, CN & TOB 3 (6.5%)
K, CN, A & TOB 5 (11%)
K, CN, A, NET & TOB 29 (63%)
Total resistance to aminoglycosides 46
CN: gentamicin , A: amikacin , K: kanamycin , NET: netilmicin , 
TOB: tobramycin.
Table 4.  The distribution of aminoglycoside resistance of 
S. aureus isolates in association with cefoxitin 
resistance.
S. aureus isolates No. CN A K NET TOB
MRSA 39 34 35 38  28  34
MSSA 9 3 5 8  1  5
Total 48 37 40 46  29  39
MRSA; methicillin resistant S. aureus, MSSA; methicillin sensitive 
S. aureus CN; gentamicin, A; amikacin; K: kanamycin; NET; 
netilmicin; TOB: tobramycin
Table 5.  The frequency of aminoglycoside resistance genes 
among S. aureus isolates.
Aminoglycoside 
suceptible  
S. aureus No.2
Aminoglycoside 
resistant   
S. aureus No.46
Type of genes
1 26 aac(6’)-Ie+aph(2’’)
0 22 aph(3’)-IIIa
0 1 ant(4’)-Ia
1 17 Total no. 
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Table 6.  The distribution of genes encoding aminoglycoside 
modifying enzymes and mecA gene in association 
with cefoxitin resistance.
Resistance 
genes
MRSA
No= 39
MSSA
No= 9
Total
No= 48 (%)
aac(6’)-
Ie+aph(2’’) 23 (56%) 4 (44.44%) 27 (56.25%)
aph(3’)-IIIa 20 (51.28%) 2 (22.22%) 22 (45.83%)
ant(4’)-Ia 1 (2.56%) 0 (0%) 1 (2.08%)
mecA 34 (87.18%) 9 (100%) 43 (89.58%)
MRSA:  Methicillin resistant S. aureus, MSSA: Methicillin sensitive 
S. aureus
Table 7.  The correlation between aac(6’)-Ie+aph(2’’) gene 
and mecA gene in S. aureus isolates. 
P value PCR results for mecA PCR results 
for aac(6’)-
Ie+aph(2’’)
0.007
 No. of 
negative
No. of 
positive
5 16 21 (negative)
0 27 27 (positive)
5 43 Total = 48
Table 8.  The correlation between aph(3’)-IIIa gene and 
mecA gene in S. aureus isolates. 
P value PCR results for mecA PCR results 
for aph(3’)-
IIIa
0.030
 No. of 
negative
No. of 
positive
 5  21 26 (negative)
 0  22 22 (positive)
 5  43 Total = 48
Table 9.  Presence of mecA gene and genes coding for 
aminoglycoside resistance and observed pheno-
typic aminoglycoside resistance.
TOB NET K A CN No %
Genotype mec 
A/aac/aph/ant
19 16 20 19 20 20 +/+/+/-
6 3 6 3 5 7 +/+/-/-
1 0 2 2 0 2 +/-/+/-
1 1 1 1 1 1 -/-/-/+
8 5 13 10 7 14 +/-/-/-
0 0 0 0 0 0 +/+/-/+
0 0 0 0 0 0 +/+/+/+
0 0 0 0 0 0 +/-/+/+
4 4 4 4 4 4 -/-/-/-
several genes in a single reaction has the advantage of identi-
fying genotypic resistance for several antibiotics more rapidly 
and reliably than other methods. Several studies have used 
multiplex PCR for the detection of genes encoding oxacillin-
resistance in staphylococcal isolates (9, 13, 14). 
This study showed that 6/48 S. aureus isolates were negative 
by the slide coagulase test, but were positive by tube coagu-
lase test and they were positive. The rate of MRSA isolates 
was 81.25% using cefoxitin disc. This result was higher than 
that obtained by Schmitz et al. 1999 (7) (27.7%), Kim et 
al., 2002 (15) (64%) and Choi et al. 2003 (12) (53%). These 
different rates of MRSA may be attributed to variations of 
patient populations, the biological characteristics of the 
S. aureus strains. 
The present study found that cefoxitin disc diffusion method 
and presence of mecA gene were not identical in 9 of S. au-
reus isolates. which were cefoxitin susceptible/mecA positive 
and 5 S. aureus isolates which were cefoxitin resistant/mecA 
negative. In the case of the 9 cefoxitin susceptible/mecA posi-
tive isolates, certain auxiliary genes such as femA, mecR and 
genes encoding β-lactamase plasmid may contribute in the 
control of its expression (12), whereas the 5 cefoxitin resis-
tant/ mecA negative isolates, non-PBP2a dependent mecha-
nisms such as hyperproduction of β-lactamases and alteration 
of PBP types which may control the expression of resistance 
(16, 17). Mechanisms of oxacillin resistance other than mecA 
are rare and include a novel mecA homologue, mecC which 
can’t be detected by tests used for detection of mecA or PBP 
2a (6, 18). Therefore, cefoxitin disc diffusion test may give 
false results. Detection of mecA gene is now considered the 
gold standard method, mainly because phenotypic method 
using cefoxitin may be difficult to interpret and some isolates 
do not express mecA unless selective pressure via antibiotic 
Discussion
Multi-drug resistance is frequently observed among staphylo-
cocci clinical isolates worldwide. Therefore, this pathogen is 
of greatest concern because of its potential virulence, its abil-
ity to cause a diverse array of life- threatening infections and 
its capacity to adapt to different environmental conditions (1). 
 Although culture-based methods are generally reliable for 
detecting oxacillin-resistant staphylococci. The detection of 
mecA gene by PCR assay is considered as the gold standard. 
In particular, multiplex PCR assay that simultaneously detects 
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treatment is applied (6). In addition, This study demonstrated 
discrepancy between the results of oxacillin and cefoxitin disk 
diffusion method in the form of 2 oxacillin resistant/cefoxi-
tin susceptible isolates but non of these isolates were mecA 
positive by PCR method; similar results was occurred in other 
studies (19, 20) . 
 Aminoglycoside resistance has been reported to be common 
in S. aureus isolated from various countries, especially in de-
veloping countries (21). In this study, 96% of the 48 S. aureus 
isolates were resistant to at least one of the tested amino-
glycoside. The highest staphylococcal resistance was to ka-
namycin (96%), while the lowest resistance was to netilmicin 
(60%). This result may be explained by the fact that netilmicin 
is seldom prescribed in our hospitals. Partial similar results 
were reported by Hauchild et al., 2008 (22), who found that 
97.8% of the 45 staphylococcal isolates were resistant to 
kanamycin while all isolates were susceptible to netilmicin.
Among staphylococci, the most frequently encountered AME 
is the bifunctional enzyme 6′-N-acetyltransferase- 2″-O-phos-
photransferase [AAC(6′)-APH (2″)], encoded by the aac(6′)-Ie-
aph(2″) gene (7). This bifunctional enzyme inactivates a broad 
range of clinically useful aminoglycosides by acetylation of an 
aminogroup and phosphorylation of a hydroxyl group. Addi-
tional enzymes such as 4′-O-adenyltransferase I [ANT(4′)-I] is 
encoded by ant(4′)-Ia gene. Finally, 3′-O-phosphotransferase 
III [APH(3′)-III] is encoded by aph(3′)-IIIa (7, 13, 23).
 In our study, the frequency of the genes encoding AMEs, 
aac(6’)-Ie+aph(2’’) encoding the bifunctional enzyme 
AAC(6’)-Ie+APH (2’’) was the most common (56.5%), fol-
lowed by the aph(3’)-IIIa encoding the APH(3’)-IIIa enzyme 
(48%) and the ant(4’)-Ia gene encoding for the ANT(4’)-Ia 
enzyme (2%). Similar results were reported by Fatholahza-
deha et al., 2009 (24) who found that the most prevalent 
AME genes were aac(6’)-Ie+aph(2’’) (83%) and aph(3’)-IIIa 
(71%) and the least frequent AME gene among MRSA iso-
lates was ant(4’)-Ia gene (26%). Similarly, Choi et al., 2003 
(12) reported that the gene encoding the bifunctional en-
zyme was the most frequently encountered gene. This may 
be explained by the fact that the gene for this bifunctional 
enzyme is part of a composite transposon Tn4001, which 
is widely distributed in both S.aureus and coagulase nega-
tive staphylococci that facilitated its rapid dissemination in 
the presence of selective antibiotic pressure (8). In another 
study carried out by Schmitz et al. 1999 (7)., the aac(6’ )-Ie+ 
aph(2” ), ant(4′)-Ia and aph(3′)-IIIa were found in a preva-
lence of 68%, 48% and 14%, respectively of staphylococci 
resistant to at least one aminoglycoside throughout Europe 
and the prevalence of ant (4′)-Ia and aph(3′)-IIIa genes was 
significantly greater than that reported in previous European 
studies. Schmitz et al. 1999 (7) explained the change in the 
prevalence of genes encoding AME due to changes in antibi-
otic policy and the type of used aminoglycoside, the introduc-
tion and consequent inter-hospital spread of resistant strains, 
especially MRSA or the possibility that these resistance genes 
could be originated from an environmental source. On the 
other hand, the study conducted by Ida et al., 2001 (25) 
in Japan showed higher prevalence of ant (4′)-Ia than that 
of the other two genes. Similar results were also reported 
by Hauschild et al., 2008 (22). Also, the study conducted 
by Yadegar et al., 2009 (21),showed that ant(4′)-Ia was the 
most frequent gene (58%), followed by aac(6’ )-Ie+ aph
(2”) and aph(3′)-IIIa genes were found in 46% and 6% of 
the isolates, respectively.
Figure 1. Demonstration 
of mecA gene and the 3 
AME genes determined 
with multiplex PCR in 
agarose gel. M; molecular 
size marker, 491 bp band; 
aac(6′)/aph(2′′) gene; 314 
bp band; mecA gene; 242 
bp band; aph(3′)-IIIa gene, 
135 bp band; ant(4′)-Ia 
gene. 15-23 test isolates.
mecA (314 bp)
ant(4′)-Ia (135 bp)
aph(3′)-IIIa (242 bp)
aac(6′)/aph(2′′) (491 bp)
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In our study, coexistence of aac(6’)-Ie+aph(2’’) with aph(3’)-
IIIa was seen in 41.66% of isolates. Higher results (71%) 
were recorded by Fatholahzadeha et al., 2009 (25). This 
study revealed no significant agreement between presence 
of mecA gene and aac(6’)-Ie+aph(2’’) (62.8% ) and aph(3’)-
IIIa (51.2%). This result was similar to the findings of Ardic 
et al., 2006 (26) which reporting corresponding frequencies 
for aac(6’)-Ie+aph(2’’) ( 66%) but rather lower frequency for 
aph(3’)-IIIa (8%). A study conducted by Schmitz et al. 1999 
(7). reported the following frequencies: 67%, and 20% for 
aac(6’)-Ie+aph(2’’) and aph(3’)-III ,respectively, and similar re-
sults was reported by Campoccia et al., 2008 (27). Overall, 
it seems that the prevalence of aac(6’)-Ie+aph(2’’) among 
methicillin-resistant staphylococci is rather consistent in most 
studies due to the adjacent locations of mecA and of AME 
encoding genes (26). The detection of resistance genes in 
antibiotic susceptible S.aureus isolates may be due to the fact 
that AME of these strains display lower enzymatic activity 
(21,23). However, the study of Ida et al. 2001 (25), reported 
that all isolates carrying the aac(6’ )-Ie+ aph(2” ) gene were 
resistant to gentamicin. Therefore, they were able to detect 
the production of the bifunctional enzyme AAC(6’ )-Ie + 
APH(2” ) by susceptibility testing with gentamicin. Similar re-
sults were reported by Yadegar et al., 2009 (21) who found 
that all isolates harboring the aac(6’ )-Ie+ aph(2” ) gene were 
resistant to gentamicin.
The present study revealed that the gene for the bifunctional 
enzyme was absent in 12 gentamicin-resistant isolates. Udo 
and Dashti, 2000 (28) reported also that this gene was de-
tected in all gentamicin-resistant isolates except two. In both 
isolates this gene could not be detected by PCR and dot blot 
hybridization. Such observation could be explained by the 
presence of another variant of the enzyme that could not be 
detected (23). The presence of variant gene that cannot be 
detected within the primer or that new aminoglycoside re-
sistance genes are circulating within the S. aureus population 
as explained by Hauschild et al. 2008 (22). This may be also 
attributed to loss of permeability and ribosomal alteration 
that may mediate resistance. 
 It is noteworthy to mention that our S. aureus 17 isolates in-
dicated phenotypic resistance to the tested aminoglycosides, 
none of the three genes encoding the AMEs was detected 
in these isolates. Similar results were reported by Hauschild 
et al. 2008 (23) who found that from a total of 45 isolates 
demonstrating phenotypic resistance to one of tested amino-
glycosides, 10 isolates did not harbor the tested genes encod-
ing AMEs. This finding could be due to a new aminoglycoside 
resistant genes which were horizontally transferred within 
the S. aureus population. Magnet and Blanchard, 2005 (29) 
reported an explanation for the absence of genes encoding 
AMEs in resistant S.aureus strains most probably due to the 
presence of other resistance mechanisms like modification of 
the target by mutation in genes encoding ribosomal proteins, 
alteration of membrane permeability or active efflux of the 
drug. 
 This study indicates that there was a high prevalence of 
mecA and aminoglycoside resistance genes among S. aureus 
isolated from surgical I.C.Us in Kasr Al-Ainy hospitals, Cairo 
University. kanamycin resistance was the most predominant 
aminoglycoside resistance among S. aureus isolates, and 
aac(6’)-Ie+aph(2’’) was the most predominant aminoglyco-
side resistance gene followed by aph(3’)-IIIa gene. We con-
clude also that mecA gene was not detected all cefoxitin 
resistant S. aureus isolates; therefore, cefoxitin screening test 
is not sufficient to detect MRSA. A more sensitive phenotypic 
method using oxacillin minimal inhibitory concentration (MIC) 
is recommended to evaluate the susceptibility of cefoxitin disc 
diffusion method for MRSA detection. Periodic and rapid de-
tection of aminoglycoside resistance and the corresponding 
genes in MRSA isolates is needed to avoid using costly and 
high toxicity antibiotics. It is important to control develop-
ment of antibiotic resistant by monitoring potential develop-
ing of new aminoglycoside resistant genes that may be pro-
duced within S. aureus population. This procedure will help 
to establish effective antibiotic therapies and prevent noso-
comial infection as well as environmental spread of resistant 
strains. A more prudent use of aminoglycosides is required 
since aminoglycosides resistance is closely associated with 
methicillin resistance. Rapid detection of antibiotic resistance 
by PCR, particularly MRSA associated with aminoglycosides 
resistance will reduce the misuse of empirical treatment with 
broad spectrum antibiotics. 
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